Kim, J.; Choi, Y.; Yang, S.; Lee, J.; Choi, J.; Moon, Y.; Kim, J.; Shim, N.; Cho, H.; Shim, M.K.;
et al. Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses. Pharmaceutics 2022, 14, 474.
https://doi.org/10.3390/pharmaceutics14030474
AMA Style
Kim J, Choi Y, Yang S, Lee J, Choi J, Moon Y, Kim J, Shim N, Cho H, Shim MK,
et al. Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses. Pharmaceutics. 2022; 14(3):474.
https://doi.org/10.3390/pharmaceutics14030474
Chicago/Turabian Style
Kim, Jeongrae, Yongwhan Choi, Suah Yang, Jaewan Lee, Jiwoong Choi, Yujeong Moon, Jinseong Kim, Nayeon Shim, Hanhee Cho, Man Kyu Shim,
and et al. 2022. "Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses" Pharmaceutics 14, no. 3: 474.
https://doi.org/10.3390/pharmaceutics14030474
APA Style
Kim, J., Choi, Y., Yang, S., Lee, J., Choi, J., Moon, Y., Kim, J., Shim, N., Cho, H., Shim, M. K., Jeon, S., Lim, D. -K., Yoon, H. Y., & Kim, K.
(2022). Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses. Pharmaceutics, 14(3), 474.
https://doi.org/10.3390/pharmaceutics14030474